HMG and GRH performed the RNA-seq data analyses

HMG and GRH performed the RNA-seq data analyses. of genes relating to metabolism, depression and appetite. Finally, insulin signaling, in particular the down-regulation of the insulin receptor substrate 4 (Irs4) gene, may be an important event in the transition from age-related changes to Alzheimers disease specific-changes. == Summary == A combination of transcriptional profiling combined with computational analyses offers uncovered novel features relevant to Alzheimers disease inside a widely used mouse model and offers avenues for further exploration into early stages of AD. == Background == Alzheimers disease (AD) is an age-related neurodegenerative disease characterized by selective IFNA17 dysfunction and loss of neurons in specific regions Corilagin of the brain including the cortex and hippocampus [1-3]. The levels of neuronal dysfunction correlate with learning and memory space deficits that seriously impede a individuals ability Corilagin to live individually. Amyloid precursor protein (APP) and its derivatives (forms of -amyloid, A) are thought to play a central part in AD, influencing both intra- and extra-neuronal processes [4-8]. With an ageing population, AD is within the increase and could affect more than 50 million people worldwide by 2050 [9,10]. Efforts to develop fresh treatments for AD have verified unsuccessful [11-16] which likely highlights the lack of understanding of the disease, particularly its onset and early progression. AD is commonly divided into two subtypes early onset (or familial) and late onset (or sporadic) [17-21]. Early-onset AD generally presents itself before age 65 with late-onset AD developing later on in existence. Mutations Corilagin recognized in genes such asAPPand presenilin 1 and 2 (PSEN1andPSEN2) contribute to early onset AD [22-25]. Variations in many genes including apolipoprotein E (APOE) have been associated with late-onset AD, but their relationships to cause AD are unclear [26-28]. Important hallmarks of both types of AD are neurofibrillary tangles and A plaques [3,29,30]. However, their appearance, particularly neurofibrillary tangles, are likely to represent phases of the disease at which neuronal dysfunction has already begun, and it may be hard to develop treatments that efficiently target events from these phases onwards. Therefore it is essential to better understand the earlier stages of the disease that precede the onset of neurofibrillary tangles and plaques. These earlier stages are likely to lengthen over many decades in humans and focusing on them provides the greatest chance for restorative treatment. Identifying the onset and early progression of any complex age-related disease using humans or non-human primates alone is particularly challenging. Therefore, an increased understanding of the molecular and cellular processes happening during early disease phases requires the use of animal models. The mouse has been widely used to investigate sub-phenotypes of AD such as amyloidosis [31-33], reactive astrogliosis [34,35] and neuroinflammation [36-38]. However, the mouse models have not been used to identify the molecular events that occur very early during disease, prior to or in the onset of the traditional hallmarks of AD. To identify these early molecular changes we performed clustering of transcriptional profiling data generated from mouse brains that showed a range in disease severity from no to early indications of AD. We had previously applied transcript clustering to identify early molecular phases inside a mouse model of glaucoma [39-41]. With this present study, we used theAPPswePsen1de9mouse model of AD, which is definitely reported to develop plaques from 6 months of age [2,42-44]. Transcript clustering identifies age-specific changes as critical for the onset and early progression of AD in these mice. Moreover, we used clustering of transcriptional profiles to identify changes to insulin signaling as an important early event in AD. == Methods == == Mouse strains and husbandry == C57BL/6J.APPswePsen1de9mice (JR005864, [2], herein referred to as B6.APBTg) were from The Jackson Laboratory and maintained in 14/10-hour light/dark cycle. All experiments were authorized by the Animal Care and Use Committee in the Jackson Laboratory. To generate experimental mice, B6.APBTg/+mice were mated to C57BL/6 J (B6) mice to generate AD and wild-type (WT) cohorts. To minimize gene expression variance between mice, all mice in experimental cohorts were bred in the same mouse space, were aged collectively (to the degree possible) and only females were assessed..